Licorice Root with Metoprolol and Amlodipine for GERD
Licorice root (specifically deglycyrrhizinated licorice/DGL formulations) can provide benefit for GERD symptoms, but you must avoid standard licorice preparations when patients are taking metoprolol and amlodipine due to serious cardiovascular drug interactions.
The GERD Benefit Evidence
Deglycyrrhizinated licorice shows promise for GERD symptom relief. A 2025 randomized controlled trial demonstrated that GutGard® (a DGL extract with <3% glycyrrhizin) significantly improved quality of life and provided earlier resolution of heartburn and regurgitation compared to placebo, with benefits appearing within 2 weeks 1. The mechanism involves enhancing intestinal barrier integrity, upregulating tight junction proteins, and modulating inflammatory pathways rather than acid suppression 2.
The Critical Drug Interaction Problem
Standard licorice root creates dangerous interactions with both metoprolol and amlodipine through multiple mechanisms:
With Amlodipine (Calcium Channel Blocker)
- Licorice constituents (glabridin, glycycoumarin, glyasperin C) significantly induce CYP3A4 enzyme activity (up to 4-fold increase) 3
- Amlodipine is extensively metabolized by CYP3A4, and strong CYP3A inhibitors already increase amlodipine exposure by 60% 4
- This interaction could unpredictably alter amlodipine blood levels, potentially reducing blood pressure control or causing excessive hypotension
With Metoprolol (Beta-Blocker)
- Glycyrrhizin (the active compound in standard licorice) inhibits 11β-hydroxysteroid dehydrogenase type 2, causing pseudohyperaldosteronism 5, 6
- This leads to hypokalemia and hypertension—directly counteracting metoprolol's blood pressure-lowering effects
- The combination creates a dangerous scenario where you're simultaneously trying to lower blood pressure with metoprolol while licorice raises it
- Hypokalemia also increases cardiac arrhythmia risk, particularly concerning with beta-blocker therapy
Individual Susceptibility Varies Dramatically
Recent evidence shows the "epimerization phenotype"—where specific intestinal microbiota convert glycyrrhizin into 3-epi-18β-glycyrrhetinic acid, which resists hepatic metabolism and accumulates longer 6. This means some patients develop severe adverse effects at low licorice doses while others tolerate higher amounts, making dosing unpredictable.
Practical Clinical Algorithm
If the patient wants to use licorice for GERD:
- Only recommend deglycyrrhizinated licorice (DGL) products with glycyrrhizin content <3% (like GutGard®) 1
- Monitor blood pressure weekly for the first month after starting DGL
- Check serum potassium at baseline and 2-4 weeks after initiation
- Watch for signs of pseudohyperaldosteronism: muscle weakness, fatigue, worsening hypertension, or cardiac arrhythmias
Better first-line alternatives per AGA guidelines:
- Start with lifestyle modifications: avoid food 2-3 hours before bed, elevate head of bed, left lateral sleeping position, weight loss 7
- Consider alginate-containing antacids for post-meal heartburn and regurgitation 7
- If symptoms persist, initiate PPI therapy (4-8 weeks trial, can escalate to twice daily) 8
Common Pitfalls to Avoid
- Don't assume all "licorice" products are the same—standard licorice candy or tea contains full glycyrrhizin content and poses maximum risk
- Don't rely on "natural = safe"—licorice has potent pharmacological effects comparable to corticosteroids 5
- Don't ignore the patient's other medications—licorice affects multiple drug-metabolizing enzymes beyond just CYP3A4 3
- Don't forget that hypoalbuminemia increases risk—check albumin levels in elderly or malnourished patients before approving any licorice use 6
The safest approach is to use evidence-based GERD therapies (PPIs, alginates, lifestyle modifications) rather than risking unpredictable interactions with cardiovascular medications that are controlling potentially life-threatening conditions.